<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR1308.html">Part 1308
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 1308.32  Exempted prescription products.
                            </h3>
                            <p class="depth0">The compounds, mixtures, or preparations that contain a nonnarcotic  controlled substance listed in Sec. 1308.12(e) or in Sec. 1308.13(b)  or (c) or in Sec. 1308.14 or in Sec. 1308.15 listed in the Table of  Exempted Prescription Products have been exempted by the Administrator  from the application of sections 302 through 305, 307 through 309, and  1002 through 1004 of the Act (21 U.S.C. 822-825, 827-829, and 952-954)  and Sec. Sec. 1301.13, 1301.22, and Sec. Sec. 1301.71 through 1301.76  of this chapter for administrative purposes only. An exception to the  above is that those products containing butalbital shall not be exempt  from the requirement of 21 U.S.C. 952-954 concerning importation,  exportation, transshipment and in-transit shipment of controlled  substances. Any deviation from the quantitative composition of any of  the listed drugs shall require a petition of exemption in order for the  product to be exempted. A listing of the Exempted Prescription Products  may be obtained by submitting a written request to the Drug and Chemical  Evaluation Section, Drug Enforcement Administration. See the Table of  DEA Mailing Addresses in Sec. 1321.01 of this chapter for the current  mailing address.  [75 FR 10679, Mar. 9, 2010]</p><p class="depth0">Exempt Anabolic Steroid Products</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
